The 17th Annual Update in Hematologic Malignancies 2013 is a conference dedicated to emerging strategies and latest clinical and research advancements in the field of hematologic malignancies including:
- Treatment strategy for patients with myeloproliferative disorders
- Bone marrow transplantation and hematologic malignancies
- Personalized medicine and its application to hematologic malignancies
- Treatment strategies for Acute Lymphoblastic Leukemia (ALL)
- The management of infectious complications in patients with hematologic malignancies
- Immunotherapeutic strategies in the treatment of hematologic malignancies
- Treatment of Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
The 17th Annual Update in Hematologic Malignancies 2013 brings together physicians, nurses and allied health professionals.
